Clinical Trial Results:
            A Phase III, Double-blind, Multi-centre, Randomised, Parallel Group Design, Placebo-controlled, Flexible Dose Study of MCI-196 in Combination with a Calcium-based Phosphate Binder in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphosphataemia.
    
|     Summary | |
|     EudraCT number | 2006-003324-11 | 
|     Trial protocol | CZ AT GB FR ES IT DE | 
|     Global completion date | 
                                    30 Apr 2009
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    10 Nov 2016
                             | 
|     First version publication date | 
                                    10 Nov 2016
                             | 
|     Other versions | |
|     Summary report(s) | CSR Synopsis_MCI-196-E09 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
